Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| VYNE Therapeutics Inc. | 2,606,982 | reported | 29 Jan 2018 | tx 10+4,011,236−10,026,934 |
| THOMPSON DESIGNS INC | 641,026 | reported | 28 Apr 2017 | tx 2+1,923,078 |
| Crinetics Pharmaceuticals, Inc. | 338,738 | reported | 07 Apr 2020 | tx 19+3,737,458−11,453,853 |
| Terns Pharmaceuticals, Inc. | 266,948 | reported | 09 Feb 2021 | tx 9+2,675,133−1,226,107 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Feb 2021 | PURCHASE | Terns Pharmaceuticals, Inc. | 103,372 | 17.00 USD | first after silence |
| 09 Feb 2021 | CONVERSION | Terns Pharmaceuticals, Inc. | 1,933,185 | — | |
| 09 Feb 2021 | CONVERSION | Terns Pharmaceuticals, Inc. | 266,948 | — | |
| 09 Feb 2021 | PURCHASE | Terns Pharmaceuticals, Inc. | 14,275 | 17.00 USD | |
| 09 Feb 2021 | PURCHASE | Terns Pharmaceuticals, Inc. | 357,353 | 17.00 USD | |
| 09 Feb 2021 | CONVERSION | Terns Pharmaceuticals, Inc. | 50,282 | — | deriv |
| 09 Feb 2021 | CONVERSION | Terns Pharmaceuticals, Inc. | 713,203 | — | deriv |
| 09 Feb 2021 | CONVERSION | Terns Pharmaceuticals, Inc. | 98,484 | — | deriv |
| 09 Feb 2021 | CONVERSION | Terns Pharmaceuticals, Inc. | 364,138 | — | deriv |
| 03 Apr 2020 | SALE | Crinetics Pharmaceuticals, Inc. | 263,600 | 13.80 USD | |
| 03 Apr 2020 | SALE | Crinetics Pharmaceuticals, Inc. | 36,400 | 13.80 USD | |
| 07 Apr 2020 | SALE | Crinetics Pharmaceuticals, Inc. | 5,373 | 14.20 USD | |
| 07 Apr 2020 | SALE | Crinetics Pharmaceuticals, Inc. | 742 | 14.20 USD | |
| 04 Feb 2020 | SALE | Crinetics Pharmaceuticals, Inc. | 357 | 22.80 USD | |
| 04 Feb 2020 | SALE | Crinetics Pharmaceuticals, Inc. | 2,584 | 22.80 USD | |
| 04 Feb 2020 | SALE | Crinetics Pharmaceuticals, Inc. | 10,519 | 22.80 USD | |
| 20 Jul 2018 | CONVERSION | Crinetics Pharmaceuticals, Inc. | 353,590 | — | |
| 20 Jul 2018 | CONVERSION | Crinetics Pharmaceuticals, Inc. | 2,560,613 | — | |
| 20 Jul 2018 | PURCHASE | Crinetics Pharmaceuticals, Inc. | 153,180 | 20.73 USD | |
| 20 Jul 2018 | PURCHASE | Crinetics Pharmaceuticals, Inc. | 141,177 | 17.00 USD | |
| 20 Jul 2018 | PURCHASE | Crinetics Pharmaceuticals, Inc. | 7,137 | 17.00 USD | |
| 20 Jul 2018 | PURCHASE | Crinetics Pharmaceuticals, Inc. | 51,686 | 17.00 USD | |
| 20 Jul 2018 | CONVERSION | Crinetics Pharmaceuticals, Inc. | 413,040 | — | |
| 20 Jul 2018 | CONVERSION | Crinetics Pharmaceuticals, Inc. | 57,035 | — | |
| 20 Jul 2018 | CONVERSION | Crinetics Pharmaceuticals, Inc. | 1,163,311 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 09 Feb 2021.